![Josh Franklin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Josh Franklin currently works at G1 Therapeutics, Inc., as President, Chief Executive Officer & Director from 2024 and Pharmacosmos Therapeutics Inc., as President from 2022.
Postes actifs de Josh Franklin
| Sociétés | Poste | Début |
|---|---|---|
| G1 THERAPEUTICS, INC. | Directeur Général | 18/09/2024 |
Pharmacosmos Therapeutics Inc.
 Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | President | 01/05/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Pharmacosmos Therapeutics Inc.
Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | Health Technology |
